Skip to main content
Tammy L. Smith
No Rating Available
(Learn About Our Rating System)

Tammy L. Smith, MD, PhD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Neurology
Salt Lake City
801-585-6387
  • Dr. Smith is a board-certified neurologist with fellowship training in autoimmune neurology; she treats patients with a broad range of neurologic disease. Her research focuses on immune-mediated neurologic disorders with a special interest in paraneoplastic neurologic diseases and aging. Her teaching emphasizes laboratory testing in immune-mediated neurologic disorders including neural autoantibody testing strategies, assay idiosyncrasies, and interpretation of results for patient care.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Psychiatry)
  • Dr. Smith is a board-certified neurologist with fellowship training in autoimmune neurology; she treats patients with a broad range of neurologic disease. Her research focuses on immune-mediated neurologic disorders with a special interest in paraneoplastic neurologic diseases and aging. Her teaching emphasizes laboratory testing in immune-mediated neurologic disorders including neural autoantibody testing strategies, assay idiosyncrasies, and interpretation of results for patient care.

    Board Certification and Academic Information

    Academic Departments Neurology -Assistant Professor (Clinical)
    Pathology -Adjunct Assistant Professor
    Board Certification
    American Board of Psychiatry & Neurology (Psychiatry)

    Education history

    Fellowship Autoimmune Neurology - University of Utah Clinical Fellow
    Residency Neurology - Rush University Medical Center Resident
    Internship Internal Medicine - Rush University Medical Center Intern
    Professional Medical Medicine, Microbiology & Immunology - University of Utah School of Medicine M.D., Ph.D.
    Undergraduate Biology - Northeastern University B.S.

    Selected Publications

    Journal Article

    1. Hoshina Y, Seay M, Vegunta S, Stulberg EL, Wright MA, Wong KH, Smith TL, Shimura D, Clardy SL (2024). Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. J Neuroophthalmol, 45(1), 36-43. (Read full article)
    2. Hoshina Y, Abbatemarco JR, Rodenbeck SJ, Poon JT, Liu SC, Paz Soldan MM, Greenlee JE, Rose JW, Peterson LK, Johnson L, Delic A, Smith TL, Clardy SL (2024). Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Ann Clin Transl Neurol, 11(11), 2846-2854. (Read full article)
    3. Hoshina Y, Delic A, Wong KH, Lyden S, Kadish R, Smith TL, Wright MA, Shimura D, Clardy SL (2023). Vasculitis in the Central Nervous System: Etiology, Characteristics, and Outcomes in a Large Single-Center Cohort. Neurohospitalist, 14(2), 129-139. (Read full article)
    4. Noroozi Gilandehi S, Wong KH, Francis T, Wright MA, Lord J, Stehlik J, Kemeyou L, Smith T, Clardy SL (2024). Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation. Neurol Neuroimmunol Neuroinflamm, 11(2), e200196. (Read full article)
    5. Luong K, Lozier BK, Novis CL, Smith TL, Zuromski LM, Peterson LK (2024). Comparison of three methods for the detection of antibodies against muscle-specific kinase. J Immunol Methods, 526, 113627. (Read full article)
    6. Xu J, Erlendsson S, Singh M, Holling GA, Regier M, Ibiricu I, Einstein J, Hantak MP, Day GS, Piquet AL, Smith TL, Clardy SL, Whiteley AM, Feschotte C, Briggs JAG, Shepherd JD (2024). PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome. Cell, 187(4), 831-845.e19. (Read full article)
    7. Smith TL, Haven TR, Zuromski LM, Luong K, Clardy SL, Peterson LK (2023). High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting. Front Neurol, 14, 1192644. (Read full article)
    8. De Almeida BI, Smith TL, Delic A, Esquibel L, Galli J, Millsap L, Paz Soldn MM, Cortez MM, Rose J, Greenlee JE, Gundlapalli AV, Hill HR, Wong KH, Clardy SL (2023). Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of Life. Neurol Neuroimmunol Neuroinflamm, 10(3). (Read full article)

    Review

    1. Clardy SL, Smith TL (2024). Therapeutic Approach to Autoimmune Neurologic Disorders. [Review]. Continuum (Minneap Minn), 30(4), 1226-1258. (Read full article)